Superworth

West Pharmaceutical Services profit margin WST

Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.

Net margin, 12 months
17.0%
Operating margin, 12 months
20.5%
Net margin on a year earlier
+0.5 pts
Peer median
13.5%

Over the twelve months to Jun 30, 2026, West Pharmaceutical Services kept 17.0% of its revenue as net profit, with an operating margin of 20.5% and a gross margin of 36.8%.

Five years earlier its net margin was 20.6%.

The median for 10 medical instruments and supplies stocks of a similar size is 13.5%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202516.1%19.0%35.9%
FY202417.0%19.7%34.5%
FY202320.1%22.9%38.3%
FY202220.3%25.4%39.4%
FY202123.4%26.6%41.5%
FY202016.1%19.0%35.8%
FY201913.1%16.1%32.9%
FY201812.0%14.0%31.8%
FY20179.4%14.1%32.1%
FY20169.5%13.0%33.2%
FY20156.8%9.2%32.6%
FY20148.9%12.8%31.5%
FY20138.2%11.9%31.8%
FY20126.4%10.7%30.6%
FY20116.3%9.2%28.5%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2617.0%+0.5 pts20.5%
Q1 FY2616.8%+0.7 pts20.3%
Q4 FY2516.1%−1.0 pts19.0%
Q3 FY2516.3%−1.1 pts19.5%
Q2 FY2516.5%−1.8 pts19.6%
Q1 FY2516.1%−3.3 pts19.1%
Q4 FY2417.0%−3.1 pts19.7%
Q3 FY2417.4%−1.7 pts19.9%
Q2 FY2418.2%+0.1 pts20.4%
Q1 FY2419.4%+0.3 pts22.0%
Q4 FY2320.1%−0.2 pts22.9%
Q3 FY2319.1%−2.6 pts22.0%

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

CompanyProfit margin
WSTWest Pharmaceutical Services17.0%
RMDResMed26.9%
MDLNMedlinen/m
SOLVSolventum17.3%
BDXBecton, Dickinson and4.5%
PENPenumbra10.7%
COOCooper Companies13.5%
ALGNAlign Technology10.0%
GMEDGlobus Medical17.0%
PODDInsulet12.3%
MSAMSA Safety16.1%
Peer median13.5%

Where West Pharmaceutical Services ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.